FDA’s Gottlieb raises ‘concern’ over Walgreens, CVS selling CBD products

Toya Sarno | Bloomberg | Getty Images

Scott Gottlieb, commissioner of the Food and Drug Administration (FDA) listens during a House Oversight and Investigations Subcommittee hearing in Washington, D.C., March 8, 2018.

Outgoing Food and Drug Administration Commissioner Scott Gottlieb told lawmakers Wednesday that he’s uneasy about Walgreens’ and CVS’ recent decisions to start selling CBD products in their drugstores.

Gottlieb tweet

Congress legalized hemp-derived CBD late last year. However, the FDA says companies still can’t add CBD to food or sell it as a dietary supplement. Selling CBD-infused beauty and skin-care products is viewed as far less risky.

The FDA and the Federal Trade Commission on Tuesday sent three warning letters to companies allegedly making unproven claims about CBD treating ailments like cancer, Alzheimer’s disease and others.

WATCH: FDA commissioner on what’s next for e-cigs after he resigns

Source link

Leave a Comment

Oklahoma drops several claims in opioid case against J&J, TevaChemotherapy doses review after 14 NHS Tayside patients die